Normothermic machine perfusion to re-evaluate declined donor livers and shorten transplant waiting time
Official title: Pilot, Open, Prospective, Randomized, Multicenter Trial On Quality Assessment Of Declined Liver Grafts By Normothermic Ex Vivo Machine Perfusion For Decreasing Time To Transplantation
Run by Charite University, Berlin, Germany · NCT06874296 · Data updated 2026-11-12
This trial tests whether keeping declined donor livers functioning on a normothermic perfusion machine can make more livers usable and help adults on the transplant waiting list (ReMELD‑Na ≤21) get transplanted sooner.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 186 (estimated) |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 10 sites (Hamburg, Free and Hanseatic City of Hamburg and 9 other locations) |
| Status | Recruiting |
| Started | June 2, 2025 |
| Main results expected | May 31, 2029 |
| Study ends | December 31, 2030 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT06874296 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) listed as transplantable at a participating center with ReMELD‑Na ≤21 (MELD ≤25), able to consent and medically suitable for transplantation with extended-criteria donor organs, who are not listed for retransplantation, high-urgency, or combined-organ transplant.
✕Probably not a fit
Patients listed for retransplantation, high-urgency or combined-organ transplants, pregnant patients, or those with higher MELD scores or special exception status are not eligible and would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled study enrolls adults listed for liver transplantation with a ReMELD‑Na score ≤21 who are not eligible for non-standard exceptions. Participants are randomized to standard organ offers or to a group that, in addition to standard offers, may be offered livers previously declined that are re-assessed using normothermic machine perfusion (NMP), which keeps the organ working outside the body for objective quality testing. The trial examines whether NMP-based reassessment increases organ utilization, shortens waiting time, and improves post-transplant survival and clinical outcomes compared with current practice. It is conducted at three major German transplant centers and is the first randomized study to test NMP reassessment of declined grafts in this patient population.
Why it matters
Potential benefit: If successful, more donor livers could be used and eligible patients could receive transplants sooner with potentially better outcomes.
How similar studies have gone: Non-randomized studies from the UK, Netherlands, Australia, and the USA have shown NMP can increase organ utilization, but randomized evidence testing reassessment of declined grafts has been lacking until this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to consent * ≥ 18 years old * Listed in status "transplantable" by the transplant conference of the study centre for liver transplantation, according to the guidelines of the German Medical Association valid at the time of inclusion * ReMELD-Na-Score ≤ 21 (equivalent to MELD ≤25), not eligible for \[non\]standard exceptions * Medically suitable and informed for transplantation with an organ that fulfils extended donor criteria (Eurotransplant ECD criteria) * Patient information and written consent to participate in the Extra trial * No participation in another interventional study during participation Exclusion Criteria: * Listed for retransplantation * High-Urgency Listing * Listed for combined organ transplantation * Pregnancy
Where it's running
-
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, Germany Recruiting -
University Hospital RWTH Aachen
Aachen, North Rhine-Westphalia, Germany Recruiting -
University Hospital Bonn
Bonn, North Rhine-Westphalia, Germany Recruiting -
University Hospital Muenster
Münster, North Rhine-Westphalia, Germany Recruiting -
Department of Surgery Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany Recruiting -
Department of General, Visceral and Transplant Surgery, Hannover Medical School
Hanover, Germany Recruiting
Show 4 more locations
-
Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich
München, Germany Recruiting -
Department of Surgery, University Hospital Regensburg
Regensburg, Germany Recruiting -
Eberhard Karls University of Tübingen, Department of General Visceral and Transplant Surgery
Tübingen, Germany Recruiting -
Department of General, Visceral, Transplantation, Vascular, and Pediatric Surgery, University Hospital Wurzburg
Würzburg, Germany Recruiting
Study contacts
- Study coordinator: Nathanael Raschzok, MD
- Email: nathanael.raschzok@charite.de
- Phone: +49 30 450 552 001
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Everolimus-based calcineurin-free immunosuppression one year after liver transplant
This trial tests whether switching to or using everolimus with reduced calcineurin inhibitors after year one post-liver transplant can protect kidney function while maintaining graft health in adults at low rejection risk.
-
Modeling liver blood flow during surgery
This study is testing a new way to predict blood flow changes during liver surgeries to help doctors choose the right patients and reduce the risk of liver failure after surgery.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Preoperative CIMT and Intraoperative Hemodynamics in Liver Transplant
This study looks at whether a higher carotid IMT measured before surgery is linked to more unstable blood pressure during liver transplant.
-
Metastatic liver cancer patient registry from multiple Chinese centers
This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.
-
Reference framework for outcomes after machine-preserved liver transplantation in Europe
This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.